Linköping University
Linköping, Sweden
NCT Number: NCT03441490
The purpose of this study is to evaluate the effects of learning support and chat on treatment outcome in internet-administrated cognitive behaviour therapy (ICBT) for adolescents with anxiety.
Looking for future studies?
Notify Me15 year–19 year
All sexes
Interventional
Not applicable
Linköping, Sweden
The study is set up as a factorial design with two independent variables: 1: Learning support and 2: chat-sessions in real time. The intervention tested is based on cognitive behavior therapy delivered over the internet via a secure treatment platform. Participants in the study are recruited from the general public via social media. The intervention is in Swedish.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Internet-based cognitive behavioural therapy with therapeutic guidance through mail, 8 weeks.
Internet-based cognitive behavioural therapy with therapeutic guidance through chat, 8 weeks.
Internet-based cognitive behavioural therapy with learning support and therapeutic guidance through mail, 8 weeks.
Internet-based cognitive behavioural therapy with learning support and therapeutic guidance through chat, 8 weeks.
Time frame: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures clinical anxiety. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Time frame: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures clinical depression. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Time frame: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures the tendency of youth to engage in excessive, generalized and uncontrollable worry. Respondents rates each item on a 4-point Likert scale consisting of never (0), sometimes (1), often (2) and always (3). The scores from each item are summed together to yield a total score that ranges from 0-42, with higher scores reflecting higher levels of worry. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Time frame: First week of treatment and then once a week during the treatment-period, two weeks post treatment, six months post treatment and 12 months post treatment.
Measures severity of generalised anxiety.
Time frame: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures clinical social phobia. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Time frame: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures fearful cognitions associated with panic attacks and agoraphobia. The ACQ consists of 14 items which will be scored as a total scale in this study. worry. Respondents rates each item on a 5-point Likert scale consisting of never (1), Thought never occurs (2), Thought rarely occurs (3) Thought occurs during half of the times when I am nervous (4) Thought usually occurs (5) Thought always occurs when I am nervous. ACQ can be divided into two subscales: Loss of Control and Physical Concerns. Each of the subscales consists of 7 items.The total scores (or the subscales) are calculated by averaging the responses to the individual items composing that score. Higher scores indicates higher levels of fearful cognitions. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Time frame: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures global cognitive judgements of one's life satisfacation as a whole, on a 5-item scale. Respondants rates how much they agree or disagree on a 7-pont scale ranging from (7) strongly agree to (1) strongly disagree, where higher scores indicates higher levels of life satisfaction. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Time frame: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Evaluates individual self-esteem. The scale is a ten item Likert scale with items answered on a four point scale, from (0) strongly agree to strongly disagree (3), where higher scores indicates higher self-esteem. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Time frame: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures alcohol consumption, drinking behaviors, and alcohol-related problems. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Time frame: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
A brief 16-item questionnaire that measures explicit, declarative knowledge about core CBT-principles and therapeutic points. Higher scores indicates more knowledge. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Linkoeping University
Other Gov
Internet-delivered Cognitive Behavioural Therapy for Adolescents With Anxiety: A Factorial Design
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06942637
Adolescents, Anxiety
Bandung, West Java, Indonesia
View Trial DetailsNCT07739381
Anxiety, Anxiety Disorders
Kütahya, Turkey (Türkiye)
View Trial DetailsNCT07421063
Anxiety, Anxiety Disorders
Bolu, Turkey (Türkiye)
View Trial DetailsNCT05438446
Anxiety, Anxiety Disorders
Athens, Attica, Greece
View Trial Details